Clinical Trial Results: A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and immune response of varying doses of a COVID-19 vaccine in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Virus Diseases

Drugs mentioned

• GlaxoSmithKline COVID-19 vaccine (unspecified)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Virus Diseases | Phase 1 | Status: COMPLETED | Results posted: 2026-08-24